Drug Repurposing Call to Treat Chronic Respiratory Infection
Funds UK-led consortia repurposing drugs for bronchiectasis and cystic fibrosis.
LifeArc runs this call as part of its Translational Challenge in Chronic Respiratory Infection, following a joint workshop it held with the MRC in 2022 that identified the unmet needs of people with bronchiectasis and cystic fibrosis. Funding progresses through milestones tracked in joint steering group meetings that include LifeArc, rather than being paid as a single sum, and is decided in two st…
The call wants consortia developing repurposed, repositioned or de-prioritised therapeutics that target the cycle of infection, inflammation and lung damage in bronchiectasis and cystic fibrosis — including improving muco-ciliary clearance, treating infection or reducing inflammation. New drug discovery, high-throughput screening and standalone biomarker or model development are explicitly excluded.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
Write proposalGrant Concept Note Example: Pre-Proposal Structure for Startups
See a practical grant concept note example, with a worked deeptech pre-proposal, section map, invite-to-full logic, and reviewer checks.
More from LifeArc
All grants from this funder →LifeArc Early Ventures
🇬🇧LifeArc · United Kingdom
Funds early-stage life science ventures with seed and Series A equity across therapeutics and medical device innovation.
LifeArc Rare Disease Clinical Trials Programme
🇬🇧LifeArc · United Kingdom
Supports clinical rare-disease teams with practical trial design and execution.
LifeArc and Action Medical Research Fund
🇬🇧LifeArc · United Kingdom
Co-funds UK translational research turning rare-disease science into treatments.
LifeArc Gene Therapy Innovation Fund
🇬🇧LifeArc · United Kingdom
Funds promising gene therapies for rare conditions through LifeArc's Gene Therapy Innovation Fund.
LifeArc KT Innovation Fellowship
🇬🇧LifeArc · United Kingdom
Supports career fellowship for early career European life scientists entering technology transfer travel expenses only no stipend.
LifeArc Philanthropic Fund
🇬🇧LifeArc · United Kingdom
Funds rare-disease therapeutics, devices and diagnostics from academics and early-stage spinout companies.
Similar grants
Browse the directory →
Prevention and management of chronic non-communicable diseases in children and young people
🇪🇺European Commission · European Union
Funds implementation research that helps children and young people prevent and manage chronic disease equitably.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
AI Predictive Biomarkers for Chronic Diseases
🇪🇺European Commission · European Union
Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.
Osteoarthritis Treatments Research Consortium
🇬🇧Arthritis UK · United Kingdom
Funds a UK osteoarthritis drug-development consortium, up to £3 million over 5 years.
Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.
EIC Transition Open
🇪🇺EIC · European Union
Supports European deep-tech ventures advancing laboratory research toward validated prototypes and near-market technologies.